Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-07
1999-06-22
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514210, 514269, 514309, 514312, 514318, 514326, 514340, 514343, 514369, 548186, 548189, 546141, 546153, 546193, 546209, 5462681, 5462761, 546275, 546283, 544238, 544298, 544408, 544360, 544333, 544372, 544359, C07D40112, C07D40312, C07D41712, A61K 31505, A61K 3150, A61K 31495, A61K 31425
Patent
active
059143282
ABSTRACT:
Novel heterocyclic ether compounds of the formula: ##STR1## wherein *, A,B, n, R.sup.1, R.sup.2 and X are specifically defined, or pharmaceutically-acceptable salts or prodrugs thereof, which are useful in selectively activating or inhibiting neurotransmitter release; to therapeutically-effective pharmaceutical compositions of these compounds; and to the use of said compositions to activate or inhibit neurotransmitter release in mammals.
REFERENCES:
patent: 4592866 (1986-06-01), Cale, Jr.
patent: 4643995 (1987-02-01), Engel et al.
patent: 4705853 (1987-11-01), Cale
patent: 4946836 (1990-08-01), Engel et al.
patent: 4956359 (1990-09-01), Taylor, Jr. et al.
patent: 5037841 (1991-08-01), Schoehe et al.
K. Tomioka et al., Stereoselective Reactions XIX. Asymmetric Dihydroxylation of Olefins by Employing Osmium Tetroxide-Chiral Amine Complexes, Chem. Pharm. Bull., 1990, 38:2133-5.
Abbott Labs, Chemical Abstract 122:187598 for WO 94/08992 (Apr. 28, 1994), With the Printout.
Burger, Medicinal Chemistry, 3rd Ed (1970), pp. 72-77.
Silverman, The Organic Chemistry of Drug Design and Drug Action, (1992), pp. 19-21.
Abreo Melwyn A.
Elliott Richard L.
Gunn David E.
He Yun
Holladay Mark W.
Abbott Laboratories
Browder Monte R.
Ford John M.
Janssen Jerry F.
Ward Michael J.
LandOfFree
Heterocyclic ether compounds useful in controlling neurotransmit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic ether compounds useful in controlling neurotransmit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic ether compounds useful in controlling neurotransmit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1708269